Biotech Grw Tst PLC Transaction in Own Shares

 
TIDMBIOG 
 
For immediate release 
 
                                                                7 February 2020 
 
THE BIOTECH GROWTH TRUST PLC 
 
                                (the "Company") 
 
                    MARKET PURCHASE OF COMPANY'S OWN SHARES 
 
Notification is given, pursuant to the authority granted at a General Meeting 
of the Company held on 27 January 2020 to make market purchases of the 
Company's own shares up to an aggregate maximum of 6,127,729 that a market 
total of 204,223 Ordinary shares of 25p each in the capital of the Company were 
purchased today for cancellation by the Company at a price of 953.24 pence per 
share. 
 
Following this transaction and in conformity with the provisions of the 
Transparency Directive, the Company hereby notifies the market that the total 
number of Ordinary shares that the Company has in issue, less the total number 
of Ordinary shares bought back for cancellation by the Company following such 
purchase, and therefore, the total number of voting rights in the Company is 
40,199,614. The Company does not currently hold any Ordinary shares in 
treasury. 
 
The figure of 40,199,614 may be used by shareholders as the denominator for the 
calculation by which they may determine if they are required to notify their 
interest in, or change to their interest in, the Company under the FCA's 
Disclosure Guidance and Transparency Rules. 
 
For and on behalf of 
 
Frostrow Capital LLP 
 
Company Secretary 
 
For further information, please contact: 
 
Mark Pope 
 
Frostrow Capital LLP 
 
Tel: [phone] 
 
 
 
END 
 

(END) Dow Jones Newswires

February 07, 2020 12:04 ET (17:04 GMT)